Improved predictive model for presymptomatic mild cognitive impairment and Alzheimer's disease

Neurological Research

Volumn 30, Issue 10, 2008, Pages 1091-1096

  Smith, Charles D ^a,c   Chebrolu, H ^a   Markesbery, W R ^a   Liu, J ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Ohio University   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Brain morphometry; Dementia; Magnetic resonance imaging; Prediction

Indexed keywords

ACCURACY; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 57449102084     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313208X327973     Document Type: Article

References (28)

1. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999; 56: 303-308
2. Petersen RC. Clinical subtypes of Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9 (Suppl. 3): S16-S24
3. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: Predictors of dementia. Neurology 1991; 41: 1006-1009
4. Markesbery WR, Schmitt FA, Kryscio RJ, et al. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006; 63: 38-46
5. Morris JC. Mild cognitive impairment is early-stage Alzheimer disease: Time to revise diagnostic criteria. Arch Neurol 2006; 63: 15-16
6. Yamaguchi H. Illustration of dynamic changes in Alzheimer pathology: From mild cognitive impairment to terminal stage. Neuropathology 2005; 25: 285-287
7. Morris JC. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics 2005; Suppl.: 9-14
8. Smith CD, Chebrolu H, Wekstein DR, et al. Brain structural alterations before mild cognitive impairment. Neurology 2007; 68: 1268-1273
9. Smith CD, Chebrolu H, Wekstein DR, et al. Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly. Neurobiol Aging 2007; 28: 1075-1087
10. Braak H, Braak E. Alzheimer's disease starts in early adulthood. Neurobiol Aging 1998; 19: S78
11. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions of different age categories. Neurobiol Aging 1997; 18: 351-357
12. Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21-36
13. Good CD, Johnsrude I, Ashburner J, et al. Cerebral asymmetry and the effects of sex and handedness on brain structure: A voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001; 14: 685-700
14. Andrea M, Price CJ, Friston KJ, et al. Voxel-based morphometry of the human brain: Methods and applications. Curr Med Imaging Rev 2005; 1: 105-113
15. Schmitt FA, Wetherby MM, Wekstein DR, et al. Brain donation in normal aging: Procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. Gerontologist 2001; 41: 716-722
16. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246
17. Liu J, Chelberg D, Smith C, et al. Distribution-based level set segmentation for brain MR Images. Presented at International Conference on Image Processing (ICIP'07), 2007, San Antonio, TX, USA
18. Chan T, Vese L. An active contour model without edges. IEEE Trans Image Process 2001; 10: 266-277
19. Chan T, Vese L. A level set algorithm for minimizing the Mumford-Shah functional in image processing. Presented at the 1st IEEE Workshop on Variational and Level Set Methods in Computer Vision, 2001, Vancouver, Canada
20. Coffey CE, Lucke JF, Saxton JA, et al. Sex differences in brain aging: A quantitative magnetic resonance imaging study. Arch Neurol 1998; 55: 169-179
21. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-878
22. Smith CD. Mild cognitive impairment is too late: The case for presymtomatic detection and treatment of Alzheimer's disease. Cogn Sci 2007; 3: 33-84
23. Gervais F, Paquette J, Morissette C, et al. Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol Aging 2007; 28: 537-547
24. Kukar T, Prescott S, Eriksen JL, et al. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. BMC Neurosci 2007; 8: 54
25. Linn RT, Wolf PA, Bachman DL, et al. The "preclinical phase" of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995; 52: 485-490
26. Whalley LJ, Starr JM, Athawes R, et al. Childhood mental ability and dementia. Neurology 2000; 55: 1455-1459
27. Finehout EJ, Franck Z, Choe LH, et al. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol 2007; 61: 120-129
28. Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 1999; 72: 771-776